Tehran University of Medical Sciences

Science Communicator Platform

Share By
Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the Sars-Cov-2 Cytokine Storm Publisher Pubmed



Torabirahvar M1 ; Rezaei N1, 2, 3
Authors

Source: Current Pharmaceutical Design Published:2021


Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to severe disease in some cases, leading to acute respiratory distress syndrome, multi-organ failure, and death. This severe phenotype seems to be associated with a cytokine storm and immune dysregulation. Increased pro-inflammatory cytokines and CD14+ CD16+ inflammatory monocytes, lymphopenia, and decreased levels of regulatory T cells are some of the immunological features that are seen in patients with SARS-CoV-2. As the outcome of SARS-CoV-2 is influenced by both viral virulence and dysregulated inflammatory response, a combination therapy approach using antiviral drugs plus anti-inflammatory treatments, such as corticosteroids, monoclonal antibodies against the IL-6 and IL-1β pathways, and JAK inhibitors are under clinical trials. © 2021 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Covid-19: From the Molecular Mechanisms to Treatment, Tanaffos (2022)
2. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)
3. Covid-19 As a Trigger of Guillain-Barre Syndrome: A Review of the Molecular Mechanism, Immunity# Inflammation and Disease (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Reza Afrisham (1)
Other Related Docs
4. Biochemical Parameters and Pathogenesis of Sars-Cov-2 Infection in Vital Organs: Covid-19 Outbreak in Iran, New Microbes and New Infections (2020)
5. The Outlook for Diagnostic Purposes of the 2019-Novel Coronavirus Disease, Journal of Cellular Physiology (2020)
6. Gastrointestinal, Liver, Pancreas, Oral and Psychological Long-Term Symptoms of Covid-19 After Recovery: A Review, Mini-Reviews in Medicinal Chemistry (2023)
7. Lymphopenia in Covid-19: Therapeutic Opportunities, Cell Biology International (2020)
8. Statins: Beneficial Effects in Treatment of Covid-19, Advances in Experimental Medicine and Biology (2023)
9. Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications, Biomedicine and Pharmacotherapy (2021)
10. Interindividual Immunogenic Variants: Susceptibility to Coronavirus, Respiratory Syncytial Virus and Influenza Virus, Reviews in Medical Virology (2021)
11. Covid-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions, Frontiers in Cell and Developmental Biology (2021)
12. An Overview of the Recent Findings of Cell-Based Therapies for the Treatment and Management of Covid-19, International Immunopharmacology (2021)
13. Hypothesis: Designation of Liposomal Scavenger System for Fight Against 2019-Ncov, Infectious Disorders - Drug Targets (2022)
14. Sars-Cov-2–A Tough Opponent for the Immune System, Archives of Medical Research (2020)
15. Efficacy of Mrna, Adenoviral Vector, and Perfusion Protein Covid-19 Vaccines, Biomedicine and Pharmacotherapy (2022)
16. The Roles of Eph Receptors, Neuropilin-1, P2x7, and Cd147 in Covid-19-Associated Neurodegenerative Diseases: Inflammasome and Jak Inhibitors As Potential Promising Therapies, Cellular and Molecular Biology Letters (2022)
17. Extracorporeal Hemoperfusion As a Potential Therapeutic Option for Severe Covid-19 Patients; a Narrative Review, Archives of Academic Emergency Medicine (2020)
18. Coronavirus Disease 2019 (Covid-19): Immune Responses, Transmission, and Clinical Features: An Update, Journal of Cellular and Molecular Anesthesia (2020)
19. The Roles of the Kynurenine Pathway in Covid-19 Neuropathogenesis, Infection (2024)
20. Symmetrical Polyneuropathy in Coronavirus Disease 2019 (Covid-19), IDCases (2020)